Published on 17 Dec 2021 on Bloomberg via Yahoo Finance
Biotech Bulls Tiptoe Into 2022 After One of the Worst Years Ever
(Bloomberg) -- Biotechnology investors and analysts are hopeful that the new year can bring a rebound for the industry which has been left in the dust by broader benchmarks.
Most Read from Bloomberg
Across the U.S., School Shooting Threats on TikTok Prompt Closures and More PoliceSouth Africa Hospitalization Rate Plunges in Omicron WaveOmicron Gets Around Previous Covid Infection, Study WarnsSinopharm, J&J, Sputnik Vaccines Are Weaker Against Omicron in New StudyDemocrats Drop Year-End Push on Biden Economic Plan Amid Discord